Tuesday, November 5, 2024
HomeTagsEPKINLY

EPKINLY

EPKINLY Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics